Severe cutaneous adverse drug reactions (SCARs) are a major cause of morbidity and mortality in Australia and recognition is important. Key diagnostic features are present early in the presentation and common drug associations exist. Clinicians should become familiar with these reaction patterns to more effectively manage these dermatological emergencies.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.